UBS ASSET MANAGEMENT AMERICAS LLC - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 97 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 2.36 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$119,820,000
-21.9%
35,555
+42.8%
0.00%
Q3 2018$153,384,000
-16.5%
24,9000.0%0.00%
Q2 2018$183,762,000
+20.7%
24,900
+7.3%
0.00%
Q1 2018$152,192,000
+72719.1%
23,200
+121.0%
0.00%
Q3 2016$209,000
+53.7%
10,5000.0%0.00%
Q2 2016$136,000
+38.8%
10,5000.0%0.00%
Q1 2016$98,000
-95.3%
10,500
-88.3%
0.00%
-100.0%
Q1 2015$2,078,000
-0.6%
89,700
-1.1%
0.00%0.0%
Q4 2014$2,090,00090,7000.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
RA Capital Management 1,026,402$21,832,0002.20%
Avoro Capital Advisors LLC 262,515$5,584,0001.54%
Lamond Capital Partners LLC 68,780$1,463,0001.48%
Green Owl Capital Management, LLC 90,000$1,914,0001.36%
Baker Brothers Advisors 4,190,594$89,134,0000.78%
SPHERA FUNDS MANAGEMENT LTD. 231,514$4,924,0000.48%
Redmile Group, LLC 238,121$5,065,0000.42%
Highlander Capital Management, LLC 19,250$409,0000.37%
Spark Investment Management LLC 110,500$2,350,0000.33%
EMERALD MUTUAL FUND ADVISERS TRUST 145,380$3,092,0000.24%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders